An open label study to confirm the effectiveness, and safety of fentanyl transdermal matrix patch in Japanese patients with chronic intractable pain who has prior therapy of codeine, morphine hydrochloride or fentanyl injectable preparations

Trial Profile

An open label study to confirm the effectiveness, and safety of fentanyl transdermal matrix patch in Japanese patients with chronic intractable pain who has prior therapy of codeine, morphine hydrochloride or fentanyl injectable preparations

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Jan 2011

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Oct 2007 Status changed from in progress to completed.
    • 15 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top